Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...natriuretic peptides...

16
Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Upload: others

Post on 15-Aug-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Μαρία Μπόνου

Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Page 2: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Pathophysiologic condition: impaired relaxation, ↓ LV compliance, ↑ LV filling pressures

DD: Diastolic Dysfunction DHF: Diastolic HF

DD DHFNormal LVEF plusSigns/symptoms of HF due to DD

Normal LVEF plusSigns/symptoms of HF not only due to DD (excluding severe valve disease, constriction etc)

HFpEF

HFpEF: HF with preserved EF

Diastolic HF

Page 3: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

1. Symptoms ± Signs

2. LVEF >50%

3. Elevated levels of natriuretic peptides(BNP > 35 pg/mL and/or NT-proBNP > 125 pg/mL)

4. At least one additional criterion:

a. Relevant structural heart disease (LVH and/or LAE)

b. Diastolic dysfunction

Eur Heart J 2016;37:2129–2200

Definition of HFpEF2016 ESC Guidelines

Page 4: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Older population

Female predominant

Comorbidities

Average: 4 Co-morbid Conditions- Hypertension- Atrial fibrillation- Coronary Artery Disease

Eur Heart J 2016;37:2129–2200

Characteristics of patients with HFpEF

Page 5: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

HFpEF Comorbitidies

Page 6: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

1 9 8 7 - 2 0 0 1 , 4 5 9 6 p t s w i t h H F

Owan et al. N Engl J Med 2006;355:251-9

Prevalence of HFpEF

Page 7: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Mortality is High in HFpEF and Similar to HFrEF

EF ≥ 50%

EF < 50%

Owan et al. N Engl J Med 2006;355:251-9

Page 8: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

• Echo plays a pivotal role in the diagnosis of diastolic dysfunction

• Don’t‘ miss a “non-HFpEF” cause of HFpEF

Diagnosis of HFpEF is challenging

Non-cardiac causes Cardiac causes

Anaemia Hypertrophic cardiomyopathy

Infiltrative or restrictive cardiomyopathy

Constrictive pericarditis

High output heart failure

Valvular heart disease

Coronary artery disease

Pulmonary embolism

Right ventricular myopathies

Page 9: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Diastolic dysfunction

Myocardial stiffness Arterial stiffness

Ventricular–Arterial (V–A) coupling

Chronotropic incompetence

Abnormal LV systolic function

Pathophysiology of HFpEF

Inadequate increase in heart rate and CO

during exercise

I N F L A M M A T I O N

Systolic Abnormalities in HFpEF Systolic Abnormalities in HFpEFDiastolic and Systolic Dyssynchrony is common in HFpEF

Echo with TDI

Mitral regurgitation

Atrial fibrillation

Exertional dyspnea and fatigue

Activity avoidance

Peripheral limitations

↓ Cardiac output reserve

Oedema, ascites and cachexia

Hoeper et al. Eur Heart J 2017; 2869–73

Page 10: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

E/e’: Marker of LV Filling Pressure

E/e’=27

Transmitral pulsed-wave Doppler

Mitral annular tissue Doppler

Assessment of LV Diastolic Function

Echocardiographic Assessment of Diastolic Function

Page 11: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

• E/A > 0,8• Normal e’ for age• E DT normal

• E/A < 0,8• ↓ e’ for age• E DT prolonged

• E/A >0,8 (often >1)• ↓ e’ for age• Look for:

↑ E/e’ and/or↑ LA size

• E/A > 1,5-2• E DT < 140 ms• ↓↓ e’ for age• ↓ A wave and a’

PEARLS

Echocardiographic Assessment of Diastolic Function

Mitter et al. JACC 2017;1451-64

Page 12: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Valsalva maneuver

Pulmonary Venous Flow

Echocardiographic Assessment of Diastolic Function

Page 13: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

• Severe impaired relaxation

• high LA pressure

• E/e’>11(septal e’)

• E/a<1(LA underfilled)

• Lateral e’ is preserved

• Respiratoryvariation

• Septal e’≥lateral e’

• Small ↑E• ↓ e’• Falsely ↑E/e’

Special Scenarios for Assessing Diastolic Function and LV Filling Pressures

Page 14: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

Algorithm for diagnosis of LV diastolic dysfunction 2016 ESC Guidelines

Diastolic Stress Testing

Heart Catheterization

Page 15: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

PATIENT WITH SUSPECTED HFpEF

Consider alternative causes

Inconclusive results

Assessment of HFpEF probability

1. Clinical History : > 60 yr of ageComorbidities

2. Physical examination 3. ECG

Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL

Cardiac echo: ejection fraction >50%

Are there complicating factors or is image quality poor? (tachycardia, bradycardia, AV block, arrhythmia, MAC, MV prosthesis, any MS, ≥3+ MR)

Assess for increased LV filling pressure (LVFP)

Likely normalSeptal E/e' < 8Lateral E/e’ < 8

IndeterminateSeptal E/e' 8-15Lateral E/e’ 8-12

Likely elevatedSeptal E/e' > 15Lateral E/e’ > 12

Check for presence of diastolic dysfunction

Average E/e’ > 14 Septal e’ < 7 cm/s or Lateral e’ <10 cm/s

TR velocity > 2.8 m/sLA volume index >34ml/m2

H E A R T C A T H E T E R I Z A T I O N

No

Perform alternative

testing(i.e. invasive

hemodynamic

testing)

Yes

Grade diastolic dysfunction

NormalE/A > 0.8

e’ normal for age Normal LA volume

Grade IE/A < 0.8

Reduced e’ for ageLAVI normal or↑

Grade IIE/A > 0.8

Reduced e’ for age↑ LAVI

Grade IIIE/A > 1.5

Reduced e’ for age ↑ LAVI, DT < 140 ms

Diastolic

Stress Testing

Page 16: Μαία Μόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό...Natriuretic peptides NT-proBNP ≥125 pg/mL, BNP ≥35 pg/mL Cardiac echo: ejection fraction >50% Are there complicating

T h a n k y o u

Diagnostic dilemmas in HFpEF